MedPath

Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia

Phase 4
Conditions
Waldenström Macroglobulinemia
Interventions
First Posted Date
2016-07-26
Last Posted Date
2016-07-26
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
110
Registration Number
NCT02844322
Locations
🇨🇳

Shuhua Yi, Tianjin, China

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Phase 2
Completed
Conditions
Acute,Leukemia, Lymphoid
Interventions
First Posted Date
2015-08-14
Last Posted Date
2022-08-03
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
30
Registration Number
NCT02523976
Locations
🇨🇳

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China

Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease

Phase 1
Completed
Conditions
Peripheral Arterial Disease
Interventions
Biological: umbilical cord mesenchymal stem cells
First Posted Date
2014-11-11
Last Posted Date
2023-02-08
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
28
Registration Number
NCT02287831

Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients

Phase 4
Completed
Conditions
Thrombocytopenia
Interventions
First Posted Date
2014-10-20
Last Posted Date
2020-03-20
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
58
Registration Number
NCT02267993
Locations
🇨🇳

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)

Phase 2
Conditions
Paroxysmal Nocturnal Hemoglobinuria
Hemoglobinuria
Hemoglobinuria, Paroxysmal
Proteinuria
Urination Disorders
Thrombosis
Bone Marrow Failure
Aplastic Anemia,
Anemia, Hemolytic
Interventions
Drug: Levamisole+cyclosporin A+Glucocorticoids
Drug: Glucocorticoids
First Posted Date
2013-01-03
Last Posted Date
2013-01-03
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
50
Registration Number
NCT01760096
Locations
🇨🇳

Institute of Hematology & Blood Diseases Hospital,, Tianjin, Tianjin, China

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Not Applicable
Completed
Conditions
Immune Thrombocytopenic Purpura
Interventions
First Posted Date
2012-11-01
Last Posted Date
2024-03-22
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
100
Registration Number
NCT01719692
Locations
🇨🇳

Hospital of Blood disease, Tianjin, Tianjin, China

Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria

Phase 2
Conditions
Hemoglobinuria, Paroxysmal
Proteinuria
Urination Disorders
Thrombosis
Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
Bone Marrow Failure
Aplastic Anemia,
Anemia, Hemolytic
Interventions
Drug: Levamisole+cyclosporin A+Glucocorticoids
Drug: Glucocorticoids
First Posted Date
2012-07-17
Last Posted Date
2013-01-03
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
120
Registration Number
NCT01642979
Locations
🇨🇳

Institute of Hematology & Blood Diseases Hospital,, Tianjin, Tianjin, China

Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

Phase 2
Conditions
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Autoimmune
Hemolysis
Hematologic Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes
Interventions
First Posted Date
2012-04-17
Last Posted Date
2012-04-19
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Target Recruit Count
100
Registration Number
NCT01579110
Locations
🇨🇳

Blood Diseases Hospital Chinese Academy of Medical Sciences, TianJin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath